MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

Washington often talks about lowering healthcare costs but ignores one of the simplest ways to do it: addressing the problem ...

A new class of weight-loss drug has shown it can significantly boost weight loss when paired with GLP-1 therapy – without ...

Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to ...

Scientists discovered that people taking weight loss medications regained pounds weeks after they stopped taking the drugs. More than 1,000 people participated in a study and their lifestyle habits ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The potential of glucagon-like peptide 1 (GLP-1) receptor agonists continues to grow more promising as new studies identify benefits beyond glucose control and weight loss. With hundreds of studies ...

For 25 years, I’ve served as a rehabilitation counselor for the deaf at MassAbility, a state agency that helps individuals with disabilities find employment and live independently. I’m also the ...

Packages of the injectable weight-loss medication Wegovy are shown (Photo illustration by Scott Olson/Getty Images) As a physician assistant in Charlotte, I have witnessed firsthand the transformative ...

In today’s Health Headlines, how anti-obesity drugs may help treat alcohol use disorder, is it okay to microdose GLP-1s, and ...